CareDx appoints Art Torres, former California state senator and transplant advocate, to board

CareDx, Inc.

Appointed Art Torres as Class III director effective Sept 15, 2021; also to Nominating and Corporate Governance Committee.
Torres is vice chair of CIRM and One Legacy; former California state senator with health policy and transplant advocacy.
Compensation: $40K annual cash retainer, initial option and RSU each with $150K grant date fair value, plus annual grants.
Torres is a colon cancer survivor and LGBTQ leader; brings patient advocacy and health equity expertise.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Arthur A. Torres

Director

CDNA · CareDx, Inc.

Effective: 2021-09-15
Filed: September 15, 2021, 7:59 PM ET

On September 11, 2021, the board of directors (the “Board”) of CareDx, Inc. (the “Company”) appointed Arthur A. Torres as a Class III director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Arthur A. Torres was appointed as Director at CareDx, Inc..

Action: appointed
Role: Director

Exact text from the filing

On September 11, 2021, the board of directors (the “Board”) of CareDx, Inc. (the “Company”) appointed Arthur A. Torres as a Class III director of the Company.

View on SEC.gov

CareDx, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-274069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.